endocancer.bsky.social
Publishing translational & clinical investigations of human health & disease focusing on #endocrine neoplasias & hormone-dependent #cancers. Owned by Society of Endocrinology.
👤 Joined on 24 June 2025
Followers
Following
Total Posts
@endocancer.bsky.socialCan GLP-1 receptor agonists, used to treat diabetes and obesity, play a role in #ProstateCancer? A new study from University of Illinois Chicago researchers, published in @endocancer.bsky.social, explores the link. Read more: https://bit.ly/4kRIonU
Show PostI did my PhD on the RET proto-oncogene & the rare cancer syndrome Multiple Endocrine Neoplasia. I learnt the value of studying rare cancers & syndromes & how we can extrapolate knowledge to cancer more broadly. I learnt the value of multi-national collaborations. A valuable Special Collection #RET 🧪
Show Post🎉 Excited to share our new publication! Targeted inhibition of netrin–DCC axis with NP137 reverses netrin-driven survival in vitro & reduces high-grade pancreatic NEN progression in vivo. Potential therapeutic strategy for aggressive PNENs? bit.ly/435pKBx @endocancer.bsky.social
Show PostExplore the latest in #pheochromocytoma & #paraganglioma research with Endocrine-Related Cancer’s (@endocancer.bsky.social) special collection, featuring recent advances in genetics, metabolomics, nuclear medicine & more. Explore the collection: erc.bioscientifica.com/page/PPGL
Show PostCharis was a huge supporter of young cancer researchers and would strongly encourage them to take on this kind of challenge! I strongly urge early Career investigators to consider submitting to this collection!
Show Post